Effects of a Walking-Based Physical Activity Intervention on Health Indicators in University Students: Protocol for a Randomized Controlled Trial.

The trial will compare an intervention group receiving a structured walking program against a control group that only records steps without personalized goals or feedback.

• Intervention group (n=99) and control group (n=99) will be randomly selected.
• The intervention group will participate in a 14-week walking program with individualized daily goals, self-monitoring, personalized feedback, and weekly educational material.
• The control group will only record their steps without receiving personalized goals or feedback.
• All participants will be assessed at the beginning and end of the intervention.

The trial will measure multiple health indicators including cardiorespiratory fitness, muscle strength, and body composition.

• Health indicators, cardiorespiratory fitness, muscle strength, and body composition will all be assessed.
• Assessments will occur at baseline and at the end of the 14-week intervention.
• Initial assessments are scheduled from March 2, 2026, to March 13, 2026.
• Final evaluations will be performed from June 22, 2026, to July 6, 2026.

The study targets the university student population, in which physical inactivity is described as a prevalent problem.

• 1 in 4 adults is physically inactive, a situation that also occurs in the university population.
• Regular participation in physical activity brings improvements in health indicators such as cardiorespiratory fitness, muscle strength, and body composition.
• The protocol is described as targeting barriers to physical activity specific to university students.

Walking was selected as the intervention modality because it can be easily incorporated into daily activities.

• The authors state that 'walking is a physical activity modality that can be easily incorporated into daily activities.'
• The protocol is described as 'a novel and feasible approach to overcome common barriers to physical activity in university students.'
• The authors note the intervention has 'potential for large-scale application in similar contexts.'

The trial is registered and follows a defined timeline with results expected by October 2026.

• The trial is registered on ClinicalTrials.gov under identifier NCT06580769.
• Recruitment process will begin in March 2026.
• The intervention will run from March 16, 2026, to June 19, 2026 (14 weeks).
• Final results of the study are expected to be published by October 2026.